Fluorescent nanofoldamers for multiplex flow cytometry

Information

  • Research Project
  • 9679921
  • ApplicationId
    9679921
  • Core Project Number
    R41GM131501
  • Full Project Number
    1R41GM131501-01
  • Serial Number
    131501
  • FOA Number
    PA-18-575
  • Sub Project Id
  • Project Start Date
    9/17/2018 - 6 years ago
  • Project End Date
    9/16/2019 - 5 years ago
  • Program Officer Name
    SAMMAK, PAUL J
  • Budget Start Date
    9/17/2018 - 6 years ago
  • Budget End Date
    9/16/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/17/2018 - 6 years ago
Organizations

Fluorescent nanofoldamers for multiplex flow cytometry

PROJECT SUMMARY/ABSTRACT Polychromatic flow cytometry (FC) is one of the most powerful analytical techniques used in immunology, basic research, and clinical medicine. In basic research, FC is a primary tool for understanding disease development at the cellular and subcellular levels. In the rapidly developing field of immunotherapy, FC is an indispensable tool for monitoring the effectiveness of new therapies and identifying key cellular subpopulations using multiple biomarkers within a panel. It plays a critical role in several growing clinical applications: development of vaccines for infectious diseases, including emerging diseases such as Ebola and Zika; characterization of immunological cells and responses related to transplantation and treatment of graft-versus-host disease; and development of vaccines and immune therapies to prevent and treat HIV infections. Increasing the number of spectrally distinct fluorophores for analysis of a single sample will give researchers greater flexibility and give clinicians a higher level of accuracy in the diagnosis and management of conditions where the size of the sample use for diagnosis is limited and for specimens with low cell numbers, such as those derived from fine needle aspiration, laparoscopy, core biopsy, and cerebrospinal fluid. Due to these small sample sizes, there are often insufficient cell numbers for multiple panels. Improvements in optics and lasers have driven the recent introduction of new fluorophores for FC. However, most of these new fluorophores have broad and often overlapping emission profiles, much like traditional fluorophores. Overlapping spectra can be resolved by the combined use of bandpass filters and mathematical compensation (overlap subtraction); however such compensation increases experimental error, reduces sensitivity, and limits multiplexing. Thus, even with a prototype 50-color instrument, leading investigators have only been able to implement a 30-parameter panel ? advances in reader technology have outstripped available capabilities in fluorophores. NIRvana Sciences is currently developing two families of tetrapyrrole fluorophores licensed from NC State University. These fluorophores offer properties that make them excellent candidates for use in polychromatic FC including ultra-violet/violet excitation, long stokes shifts into the red and near infrared spectrums along with very narrow emissions. NIRvana Sciences and the Lindsey lab are developing a polymer platform that retains the intrinsic brightness of its dyes and has strong utility to the flow cytometry reagent market.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R41
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    300000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:300000\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NIRVANA SCIENCES, INC.
  • Organization Department
  • Organization DUNS
    078769570
  • Organization City
    RESEARCH TRIANGLE PARK
  • Organization State
    NC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    277090003
  • Organization District
    UNITED STATES